Concepedia

Péter Ács

PÁ

Statistics

Publications

32

Citations

2.6K

H-Index

28

Active since

1996

Affiliations

National Institutes of Health(Current)

National Cancer Institute

Uniformed Services University of the Health Sciences

University of Pennsylvania

Florida Cancer Specialists & Research Institute

Péter Ács is an author at National Institutes of Health specializing in signal transduction, life sciences, and cell signaling.

Publications per year

1996–2019

32

Publications

32

Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial

Charles S. Fuchs, Kohei Shitara, Maria Di Bartolomeo et al. · The Lancet Oncology · 2019 · 284 citations · Full text

, , +13

Erythropoietin and erythropoietin receptor expression in human cancer.

Géza Ács, Péter Ács, S M Beckwith et al. · PubMed · 2001 · 241 citations

, , +16

Hypoxia-Inducible Erythropoietin Signaling in Squamous Dysplasia and Squamous Cell Carcinoma of the Uterine Cervix and Its Potential Role in Cervical Carcinogenesis and Tumor Progression

Géza Ács, Paul J. Zhang, Cindy McGrath et al. · American Journal Of Pathology · 2003 · 194 citations · Full text

, , +17

Characterization of Functional Vanilloid Receptors Expressed by Mast Cells

Tamás Bı́ró, Marcus Maurer, Shayan Modarres et al. · Blood · 1998 · 191 citations · Full text

, , +14

Immunohistochemical expression of erythropoietin and erythropoietin receptor in breast carcinoma

Géza Ács, Paul J. Zhang, Timothy R. Rebbeck et al. · Cancer · 2002 · 156 citations · Full text

, , +17

1–5 of 32